Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.

Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hyp...

Full description

Bibliographic Details
Main Authors: Simone Pereira-Simon, Gustavo A Rubio, Xiaomei Xia, Weijing Cai, Rhea Choi, Gary E Striker, Sharon J Elliot
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4948910?pdf=render
id doaj-0789c028e24f499585905c9bfc1f15db
record_format Article
spelling doaj-0789c028e24f499585905c9bfc1f15db2020-11-25T01:46:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015966610.1371/journal.pone.0159666Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.Simone Pereira-SimonGustavo A RubioXiaomei XiaWeijing CaiRhea ChoiGary E StrikerSharon J ElliotAge-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.http://europepmc.org/articles/PMC4948910?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Simone Pereira-Simon
Gustavo A Rubio
Xiaomei Xia
Weijing Cai
Rhea Choi
Gary E Striker
Sharon J Elliot
spellingShingle Simone Pereira-Simon
Gustavo A Rubio
Xiaomei Xia
Weijing Cai
Rhea Choi
Gary E Striker
Sharon J Elliot
Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
PLoS ONE
author_facet Simone Pereira-Simon
Gustavo A Rubio
Xiaomei Xia
Weijing Cai
Rhea Choi
Gary E Striker
Sharon J Elliot
author_sort Simone Pereira-Simon
title Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
title_short Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
title_full Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
title_fullStr Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
title_full_unstemmed Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
title_sort inhibition of advanced glycation end products (ages) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E2 replacement. Glomerular ERα mRNA expression was upregulated in mice treated with both Pyr and E2 replacement and TGFβ mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E2. Mesangial cells isolated from all groups of mice demonstrated similar ERα, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ERα, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGFβ production and by regulation of the estrogen receptor.
url http://europepmc.org/articles/PMC4948910?pdf=render
work_keys_str_mv AT simonepereirasimon inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT gustavoarubio inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT xiaomeixia inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT weijingcai inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT rheachoi inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT garyestriker inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
AT sharonjelliot inhibitionofadvancedglycationendproductsagesaccumulationbypyridoxaminemodulatesglomerularandmesangialcellestrogenreceptoraexpressioninagedfemalemice
_version_ 1725020744648228864